Metabotropic Receptor Based Target for Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus

Authors

  • Jhakeshwar Prasad Columbia Institute of Pharmacy, Vill-Tekari, Near Vidhansabha Raipur-493111, C.G. India
  • Ashish Kumar Netam Department of Pharmacology, Columbia Institute of Pharmacy, Tekari, Raipur, (CG), Pin 493111.
  • Trilochan Satapathy Department of Pharmacology, Columbia Institute of Pharmacy, Tekari, Raipur, (CG), Pin 493111.
  • S. Prakash Rao Department of Pharmacology, Columbia Institute of Pharmacy, Tekari, Raipur, (CG), Pin 493111.

DOI:

https://doi.org/10.37591/tdd.v5i1.103

Abstract

G protein coupled receptors (GPCRs) moreover called as metabotropic receptor addresses the greatest gathering of film proteins in the human genome. GPCRs share a regular essential characteristic of seven hydrophobic transmembrane (TM) sections (heptahelical structure), with an extracellular amino end and an intracellular carboxyl end their assistant and valuable closeness of GPCRs stays rather than the fundamental OK assortment of the ordinary GPCR ligands. GPCRs keep on being critical revelation focuses for the treatment of type 2 diabetes mellitus (T2DM). Diabetes as interminable metabolic issues where the pancreas can't enough produce enough insulin and the body additionally creates protection from the insulin it delivers under typical physiologic conditions. Numerous GPCRs are specifically associated with the improvement of insulin protection and β-cell dysfunction, and in the etiology of irritation that can prompt corpulence actuated T2DM. In this survey, the authors have attempted to abridge various all around approved GPCR focuses on, the improvement of novel pharmacological tests that will enable these objectives to satisfy their guarantee for the treatment of these metabolic disorders, for example, diabetes mellitus and so forth.

 

Keywords: G-protein coupled receptors, insulin, type 2 diabetes mellitus, and obesity

 

Cite this Article

Jhakeshwar Prasad, Ashish Kumar Netam, Trilochan Satapathy et al. Metabotropic Receptor Based Target for Insulin Resistance, Obesity, and Type 2 Diabetes Mellitus. Trends in Drug Delivery. 2018; 5(1): 17–27p.

Downloads

Published

2018-05-18

Issue

Vol. 5 No. 1 (2018)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.